Connect with us

Hi, what are you looking for?

Capital Business
Capital Business
US pharmaceuticals giant Pfizer/AFP

Kenya

US Pfizer, India’s Biocon scrap insulin pact

US pharmaceuticals giant Pfizer/AFP

MUMBAI, Mar 13 – India’s largest biotechnology firm, Biocon, and US pharmaceutical giant Pfizer said Tuesday they would scrap a plan to sell insulin products, sending Biocon’s shares plunging.

Biocon shares fell as much as 11.09 percent to a low of 238 rupees on the Bombay Stock Exchange following the news. The shares then retraced to 254 rupees, still down five percent.

The companies said in a joint statement the split was due to “individual priorities” for their respective businesses, adding it was “in their best interest to move forward independently.” They did not elaborate.

“The development will have a psychological impact for Biocon. It cannot find a joint venture partner like Pfizer every day,” Jagannadham Thunuguntla, head of research at SMC Global Securities, told AFP.

According to the deal struck in October 2010, Pfizer was to sell cheaper copies of diabetes products in some emerging markets and in Europe that the Bangalore-headquartered Biocon would make.

The decision to abandon the tie-up comes at a time when multinational drug makers are increasingly tying up with Indian pharmas to source cheaper generic products for sale globally.

“Biocon will work with existing partners in several countries and pursue a commercial strategy on its own and through new alliances in other markets,” its chairman Kiran Mazumdar Shaw said in the statement.

Pfizer’s general manager Diem Nguyen said the firm would “continue in active research and business development for diabetes, which represents a huge unmet need.”

Click to comment
Advertisement

More on Capital Business

Executive Lifestyle

NAIROBI, Kenya, Mar 12 – The country’s super wealthy individuals are increasing their holding of bonds, gold and cash, a new report by Knight...

Ask Kirubi

NAIROBI, Kenya, Mar 9 – Businessman and industrialist Dr. Chris Kirubi has urged members of the public to exercise extreme caution when making any...

Ask Kirubi

NAIROBI, Kenya, Mar 24 – Businessman and industrialist Dr. Chris Kirubi is set to own half of Centum Investment Company PLC, following a go-ahead...

Headlines

NAIROBI, Kenya, Mar 18 – Commercial Banks have been ordered to provide relief to borrowers on their personal loans, with loans eligible from March...

Ask Kirubi

It is without a doubt that the COVID-19 pandemic has caught the whole world by surprise. Although its full impact is yet to be...

Kenya

NAIROBI, Kenya, Jun17 – Kenya’s tea leaves manufacturer Kericho Gold, has been awarded the Superbrands Seal by Superbrands East Africa for their quality variety...

Coronavirus

NAIROBI, Kenya, Apr 13 – As the local telecommunications industry gears up to roll out 5G networks in the country, the Communications Authority of...

Coronavirus

NAIROBI, Kenya, Mar 22 – Airtel Kenya is offering free internet access for students in order to enable continued learning at home in the...